BioPharma Credit PLC (BPCR)
LSE
Real-time Data
07:00 AM
Day's Range
0.970052 wk Range
0.8760Overview - BPCR - BioPharma Credit PLC
Key Statistics
Valuation
P/E (Trailing)
‪0.08‬
Price / Sales (TTM)
‪8.31‬
Profitability
Return on Assets
‪11.11%‬
Return on Equity
‪11.28%‬
Ownership
Shares Outstanding
1.12B
Price stats
50-Day Avg
‪0.9639‬
200-Day Avg
‪0.9374‬
Dividends
Frequency
Quarterly
Market Cap - BPCR - BioPharma Credit PLC
Peers - BPCR - BioPharma Credit PLC
Peer Comparison
Compared with companies in Asset Management listed on LSE.
- BPCRLSEBioPharma Credit PLC1.09BMarket Cap+7.20%52-week change0.09P/E (Trailing)—Profit Margin
- 0NC6LSEInvestor AB ser. B639.65BMarket Cap+27.85%52-week change4.20P/E (Trailing)‪66.89%‬Profit Margin
- ALALWLSEAlliance Witan PLC508.43BMarket Cap+7.24%52-week change19.37P/E (Trailing)—Profit Margin
- ABDNLSEAberdeen Group plc453.19BMarket Cap+19.82%52-week change11.56P/E (Trailing)‪28.06%‬Profit Margin
- 0AAZLSEEQT AB424.93BMarket Cap-2.46%52-week change111.35P/E (Trailing)‪-2.63%‬Profit Margin
- 3INLSE3i Infrastructure plc364.32BMarket Cap+12.03%52-week change12.23P/E (Trailing)‪72.12%‬Profit Margin
- EMGLSEMan Group Plc337.20BMarket Cap+45.46%52-week change14.47P/E (Trailing)‪19.19%‬Profit Margin
Profile Summary - BPCR - BioPharma Credit PLC
About
BioPharma Credit PLC is a closed-ended investment company that provides investors with exposure to the fast-growing life sciences industry through a diversified portfolio of loans and other instruments backed by royalties or cash flows from approved life sciences products. Its primary objective is to generate…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
